van Baarsen, Lisa Gm <br/><br/>
Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment.  [electronic resource] 

 -  Arthritis research & therapy  2010 
 - R11 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/ar2912  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--drug therapy<br/>Female<br/>Gene Expression<br/>Gene Expression Profiling<br/>Humans<br/>Infliximab<br/>Interferon Type I--blood<br/>Male<br/>Middle Aged<br/>Oligonucleotide Array Sequence Analysis<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors